What to advise to respiratory patients intending to use electronic cigarettes

Discovery Medicine

Volumn 20, Issue 109, 2015, Pages 155-161

  Polosa, Riccardo ^a,b,c   Caponnetto, Pasquale ^a,b  

^a Centro per la Prevenzione e Cura Del Tabagismo (CPCT)   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Azienda Universitario Ospedaliera Policlinico Vittorio Emanuele   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; NICOTINE;

ARTICLE; CARDIOVASCULAR DISEASE; CHEWING GUM; CLINICAL TRIAL (TOPIC); ELECTRONIC CIGARETTE; HEALTH CARE PERSONNEL; HUMAN; META ANALYSIS (TOPIC); NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT COUNSELING; PHYSICIAN; RESPIRATORY CARE PRACTICE; RISK FACTOR; SMOKING AND SMOKING RELATED PHENOMENA; SMOKING CESSATION; ADVERSE EFFECTS; BREATHING DISORDER; COMPLICATION; EVIDENCE BASED MEDICINE; PATHOPHYSIOLOGY; PATIENT SAFETY; PROCEDURES; SMOKING; TOBACCO USE DISORDER;

ELECTRONIC CIGARETTES; EVIDENCE-BASED MEDICINE; HUMANS; NICOTINE; PATIENT SAFETY; RESPIRATION DISORDERS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84944460885     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Alpert HR, Connolly GN, Biener L. A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control 22(1):32-37, 2013.
2. Bekki K, Uchiyama S, Ohta K, Inaba Y, Nakagome H, Kunugita N. Carbonyl compounds generated from electronic cigarettes. Int J Environ Res Public Health 11:11192-11200, 2014.
3. Benowitz N, Gourlay S. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 29:1422-1431, 1997.
4. Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res 17:127-133, 2015.
5. Borrelli B, Novak SP. Nurses' knowledge about the risk of light cigarettes and other tobacco 'harm reduction' strategies. Nicotine Tob Res 9:653-661, 2007.
6. Buchhalter AR, Acosta MC, Evans SE, Breland AB, Eissenberg T. Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. Addiction 100(4):550-559, 2005.
7. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N. Electronic cigarettes for smoking cessation: A randomised controlled trial. Lancet 382:1629-1637, 2013.
8. Caponnetto P, Polosa R, Russo C, Leotta C, Campagna D. Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. J Med Case Rep 5:585, 2011.
9. Caponnetto P, Russo C, Auditore R, Polosa R. The smoker with interstitial lung disease and interventions for successful smoking cessation. Rev Port Pneumol 18(6):285-288, 2012.
10. Caponnetto P, Russo C, Bruno CM, Alamo A, Amaradio MD, Polosa R. Electronic cigarette: a possible substitute for cigarette dependence. Monaldi Arch Chest Dis 79(1):12-19, 2013a.
11. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, Polosa R. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: A prospective 12-month randomized control design study. PLoS One 8(6):e66317, 2013b.
12. Caponnetto P, Maglia M, Polosa R. Electronic cigarettes-from smoking cessation to smoking sensation and back. Addiction 110(4):678-679, 2015.
13. Dawkins L, Turner J, Roberts A, Soar K. 'Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction 108(6):1115-1125, 2013.
14. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328:1519-1528, 2004.
15. Environmental Protection Agency. EPA Report/600/6-90/006F. Respiratory health effects of passive smoking: lung cancer and other disorders. 1992. Washington, DC. Available at: http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=36793
16. Etter JF, Eissenberg T. Dependence levels in users of electronic cigarettes, nicotine gums and tobacco cigarettes. Drug Alcohol Depend 147:68-75, 2015.
17. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse 7:139-146, 2013.
18. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf 5(2):67-86, 2014.
19. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19, 000 consumers. Int J Environ Res Public Health 11(4):4356-4373, 2014.
20. Farsalinos KE, Voudris V, Poulas K. E-cigarettes generate high levels of aldehydes only in "dry puff" conditions. Addiction 110(8):1352-1356, 2015.
21. Flouris A, Chorti M, Poulianiti K, Jamurtas A, Kostikas K, Tzatzarakis M, Wallace Hayes A, Tsatsakis AM, Koutedakis Y. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 25:91-101, 2013.
22. Foulds J, Veldheer S, Yingst J, Hrabovsky S, Wilson SJ, Nichols TT, Eissenberg T Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking e-cigarette users. Nicotine Tob Res 17(2):186-192, 2015.
23. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, Jacob P 3rd, Benowitz N. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 23(2):133-139, 2014a.
24. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, Jacob P 3rd, Benowitz N. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 23:133-139, 2014b.
25. Graham I. I believe therefore I practise. Lancet 347:4-5, 1996.
26. Greenland S, Satterfield M, Lanes S. A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Safety 18:297-308, 1998.
27. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99(1):29-38, 2004.
28. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 372:392-394, 2015.
29. Kosmider L, Sobczak A, Fik M, Knysak J, Zaciera M, Kurek J, Goniewicz ML. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res 16:1319-1326, 2014.
30. Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care 14:26-33, 2005.
31. Murray RP, Bailey WC, Daniels K, Bjornson WM, Kurnow K, Connett JE, Nides MA, Kiley JP. Safety of nicotine polacrilex gum used by 3, 094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 109:438-445, 1996.
32. Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Milton A, Polosa R, Ramsey J, Sweanor D. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res 20:218-25, 2014.
33. Patwardhan SR, Murphy MA. Survey of GPs' understanding of tobacco and nicotine products. Drugs Alcohol Today 13(2):119-150, 2013.
34. Pierce JP, Cummins SE, White MM, Humphrey A, Messer K. Quitlines and nicotine replacement for smoking cessation: do we need to change policy? Annu Rev Public Health 33:341-356, 2012.
35. Polosa R, Benowitz NL. Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci 32(5):281-289, 2011.
36. Polosa R, Caponnetto P, Sands MF. Caring for the smoking asthmatic patient. J Allergy Clin Immunol 130(5):1221-1224, 2012.
37. Polosa R, Rodu B, Caponnetto P, Maglia M, Raciti C. A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J 10:19, 2013.
38. Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J 41(3):716-726, 2013.
39. Polosa R, Caponnetto P, Maglia M, Morjaria JB, Russo C. Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health 14:1159, 2014a.
40. Polosa R, Morjaria JB, Caponnetto P, Caruso M, Strano S, Battaglia E, Russo C. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. Int J Environ Res Public Health 11:4965-4977, 2014b.
41. Polosa R, Caponnetto P, Cibella F, Le-Houezec J. Quit and smoking reduction rates in vape shop consumers: a prospective 12-month survey. Int J Environ Res Public Health 12(4):3428-3438, 2015.
42. Rigotti NA. Smoking cessation in patients with respiratory disease: existing treatments and future directions. Lancet Respir Med 1(3):241-250, 2013.
43. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation tool: results from an online survey. Am J Prev Med 40(4):472-475, 2011.
44. Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev 10:CD008286, 2012.
45. Tønnesen P. Smoking cessation and COPD. Eur Respir Rev 22(127):37-43, 2013.
46. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733-748, 2013.
47. U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress: a Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2014.
48. U.S. Pharmacopeia. Elemental impurities limits. 2013. Available at: http://www.usp.org/sites/default/files/usp_pdf/EN/USPNF/key-issues/c232_final.pdf
49. Vardavas C, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly G, Behrakis P. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 141:1400-1406, 2012.
50. WHO-IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 83, Tobacco smoke and involuntary smoking. 2004. Available at: http://monographs.iarc.fr/ENG/Monographs/vol83/mono83.pdf
51. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 8:e57987, 2013.
52. Woolf K, Zabad M, Post J, McNitt S, Williams G, Bisognano J. Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes. Am J Cardiol 110:968-970, 2012.
53. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008-The MPOWER package. Geneva: World Health Organization. 2008.
54. Zhu SH, Lee M, Zhuang YL, Gamst A, Wolfson T. Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades? Tob Control 21(2):110-118, 2012.